Valeant Pharmaceuticals International, Inc. (NYSE: VRX) today commented on recent stock transactions made by Valeant's former chief executive officer, J ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Insider Trades Management Comments Momentum Movers Short Sales Trader Talk

Valeant (VRX) Investors Should Be Focused on Earnings Not Upcoming Product Catalysts - Wells FargoJuly 14, 2016 1:29 PM Ackman Feels 'Sad' for Michael Pearson on Forced Valeant (VRX) SaleJuly 14, 2016 12:23 PM Valeant Pharma (VRX) Shares Rise After Clarifying Recent Pearson Stock, Options SalesJuly 14, 2016 9:00 AM Valeant Pharmaceuticals Comments On Recent Stock TransactionsJuly 14, 2016 8:50 AM